Mg. Murer et al., CHRONIC LEVODOPA IS NOT TOXIC FOR REMAINING DOPAMINE NEURONS, BUT INSTEAD PROMOTES THEIR RECOVERY, IN RATS WITH MODERATE NIGROSTRIATAL LESIONS, Annals of neurology, 43(5), 1998, pp. 561-575
Orally administered levodopa remains the most effective symptomatic tr
eatment for Parkinson's disease (PD). The introduction of levodopa the
rapy is often delayed, however, because of the fear that it might be t
oxic for the remaining dopaminergic neurons and, thus, accelerate the
deterioration of patients. However, in vivo evidence of levodopa toxic
ity is scarce. We have evaluated the effects of a 6-month oral levodop
a treatment on several dopaminergic markers, in rats with moderate or
severe 6-hydroxydopamine-induced lesions of mesencephalic dopamine neu
rons and sham-lesioned animals. Counts of tyrosine hydroxylase (TH)-im
munoreactive neurons in the substantia nigra and ventral tegmental are
a showed no significant difference between levodopa-treated and vehicl
e-treated rats. In addition, for rats of the sham-lesioned and severel
y lesioned groups, immunoradiolabeling for TH, the dopamine transporte
r (DAT), and the vesicular monoamine transporter (VMAT2) at the striat
al level was not significantly different between rats treated with lev
odopa or vehicle. It was unexpected that quantification of immunoautor
adiograms showed a partial recovery of all three dopaminergic markers
(TH, DAT, and VMAT2) in the denervated territories of the striatum of
moderately lesioned rats receiving levodopa Furthermore, the density o
f TH-positive fibers observed in moderately lesioned rats was higher i
n those treated chronically with levodopa than in those receiving vehi
cle. Last, that chronic levodopa administration reversed the up-regula
tion of D2 dopamine receptors seen in severely lesioned rats provided
evidence that levodopa reached a biologically active concentration at
the basal ganglia. Our results demonstrate that a pharmacologically ef
fective 6-month oral levodopa treatment is not toxic for remaining dop
amine neurons in a rat model of PD but instead promotes the recovery o
f striatal innervation in rats with partial lesions.